Search research articles
Contact Us
Filters
Showing results (41-50 of 89) with videos related to
Page
of 9
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
January 18, 2012
High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis
Dimitrios Mougiakakos, Riki Okita, Takashi Ando, et al.
Oncoimmunology
|
March 12, 2020
Lactate dehydrogenase: a marker of diminished antitumor immunity
Sandra Van Wilpe, Rutger Koornstra, Martijn Den Brok, et al.
The Lancet. Oncology
|
July 6, 2023
Adjuvant immune checkpoint blockade revisited
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Atse Huisman, Anke Pisters-van Roy, et al.
World Journal of Urology
|
January 16, 2009
Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery
Axel Bex, Astrid A M van der Veldt, Christian Blank, et al.
International Journal of Cancer
|
February 17, 2006
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro
Christian Blank, Juergen Kuball, Simon Voelkl, et al.
Expert Review of Dermatology
|
November 4, 2009
Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention
Luigi Strizzi, Lynne-Marie Postovit, Naira V Margaryan, et al.
International Journal of Cancer
|
July 1, 2011
PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease
Holger Krönig, Kathrin Julia Falchner, Marcus Odendahl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 2021
Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!
Michele Maio, Christian Blank, Andrea Necchi, et al.
Journal for Immunotherapy of Cancer
|
July 12, 2022
Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins
Tim B Fessenden, Lauren E Stopfer, Fiona Chatterjee, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 21, 2024
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Wei Yen Chan, Jenny H Lee, Ashleigh Stewart, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 89) with videos related to
Sort By:
Page
of 9
Journal of Molecular Medicine (Berlin, Germany)
|
January 18, 2012
High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis
Dimitrios Mougiakakos, Riki Okita, Takashi Ando, et al.
Oncoimmunology
|
March 12, 2020
Lactate dehydrogenase: a marker of diminished antitumor immunity
Sandra Van Wilpe, Rutger Koornstra, Martijn Den Brok, et al.
The Lancet. Oncology
|
July 6, 2023
Adjuvant immune checkpoint blockade revisited
Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Atse Huisman, Anke Pisters-van Roy, et al.
World Journal of Urology
|
January 16, 2009
Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery
Axel Bex, Astrid A M van der Veldt, Christian Blank, et al.
International Journal of Cancer
|
February 17, 2006
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro
Christian Blank, Juergen Kuball, Simon Voelkl, et al.
Expert Review of Dermatology
|
November 4, 2009
Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention
Luigi Strizzi, Lynne-Marie Postovit, Naira V Margaryan, et al.
International Journal of Cancer
|
July 1, 2011
PD-1 expression on Melan-A-reactive T cells increases during progression to metastatic disease
Holger Krönig, Kathrin Julia Falchner, Marcus Odendahl, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 2021
Neoadjuvant immunotherapy is reshaping cancer management across multiple tumour types: The future is now!
Michele Maio, Christian Blank, Andrea Necchi, et al.
Journal for Immunotherapy of Cancer
|
July 12, 2022
Dendritic cell-mediated cross presentation of tumor-derived peptides is biased against plasma membrane proteins
Tim B Fessenden, Lauren E Stopfer, Fiona Chatterjee, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 21, 2024
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Wei Yen Chan, Jenny H Lee, Ashleigh Stewart, et al.
Page
of 9